Sex Supplements Often Contain Viagra Ingredients, Pfizer Inc. (PFE) Reveals
5/10/2013
More...
|
Ticagrelor Does Not Affect Pulmonary Function in ACS Patients, University of Sheffield Study
10/14/2011
More...
|
Infections After Prostate Biopsy on the Rise, NYU Langone Medical Center Study
10/14/2011
More...
|
Breast Cancer Drug Tied to Diabetes in Older Women, Women's College Hospital and University of Toronto Study
10/7/2011
More...
|
Risky Pregnancy Drug Raised Daughters' Cancer Odds, National Cancer Institute Study
10/7/2011
More...
|
Old Osteoporosis Drug May Help In Killing Flu Viruses, University of Hong Kong Study
6/29/2011
More...
|
AIDS Drugs Can Cause Premature Aging, Newcastle University Study
6/27/2011
More...
|
Drug Significantly Improves Glycemic Control in Type 1 Diabetics on Insulin, University at Buffalo Study
6/16/2011
More...
|
One in Five Heart Attack Deaths Could be Prevented with New Drug, University of Sheffield Study
6/14/2011
More...
|
Dangerous Side Effect of Common Drug Combination Discovered by Stanford University Medical Center and Collaborators Data Mining
5/26/2011
More...
|
Viagra Could Reduce Multiple Sclerosis Symptoms, Autonoma de Barcelona Study
5/20/2011
More...
|
Common Drug Helps Babies with Sickle Cell Disease, St. Jude Children's Research Hospital Study Finds
5/13/2011
More...
|
Renal Cancer Drug Temsirolimus Shows Promise Against Mesothelioma, Medical University of Vienna Study
5/2/2011
More...
|
Diabetes Treatment May Also Provide Protection Against Endometrial Cancer, University of Warwick and Warwick Medical School Study
4/6/2011
More...
|
Metformin Still Best First-Line Type 2 Diabetes Drug, Johns Hopkins University School of Medicine Study Suggests
3/15/2011
More...
|
UCB, Inc. (UCBJF.PK) Release: New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome
5/17/2013
More...
|
US WorldMeds, LLC Release: New Clinical Trial Investigates APOKYN for Treating Debilitating Morning Akinesia in Parkinson’s Disease Patients
5/13/2013
More...
|
Prometheus Laboratories Inc. Launches PROCLIVITY(SM) 01 Clinical Trial of Proleukin® (Aldesleukin for Injection) Plus Vemurafenib Therapy in Patients with Metastatic Melanoma
5/9/2013
More...
|
AlphaMed Release: Study Shows Dual Targeting of HER2 and HR-Positive Metastatic Breast Cancer Improves Survival Rates
5/7/2013
More...
|
Bristol-Myers Squibb Company (BMY) and Pfizer Inc. (PFE) Announce Publication of ARISTOTLE Subanalysis in Circulation
5/7/2013
More...
|
Genzyme Corporation (GENZ) Release: Once-Daily AUBAGIO® Delayed Onset of Clinically Definite Multiple Sclerosis (MS) in TOPIC Study
4/25/2013
More...
|
Pacira Pharmaceuticals, Inc. Release: New Data Support the Benefits of EXPAREL for Postsurgical Analgesia Following Aesthetic Plastic Surgery Procedures
4/12/2013
More...
|
Kowa Pharmaceuticals America Release: New Superiority Trial Showed LIVALO® (Pitavastatin) 4 mg Provided Significantly Greater LDL-C Reduction in HIV-Infected Adults With Dyslipidemia Versus Pravastatin 40 mg
3/7/2013
More...
|
Boehringer Ingelheim Corporation Release: New Findings From Two Studies Support Substantial Benefit of Pradaxa® for Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism
2/21/2013
More...
|
Cumberland Pharmaceuticals (CPIX) Release: Caldolor® Reduces Pain and Fever in Adult Patients
2/19/2013
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Release: New Peer-Reviewed Publication Offers Guidance for Integrating Gattex® (Teduglutide [rDNA origin]) for Injection into Management of Short Bowel Syndrome
1/30/2013
More...
|
Santarus Inc. (SNTS) and VeroScience Announce Publication of Positive Data From Pivotal CYCLOSET® (bromocriptine mesylate) Efficacy Study
1/23/2013
More...
|
Immune Response BioPharma Files for Orphan Designation of REMUNE for Pediatric HIV/AIDS
12/13/2012
More...
|
Celgene (CELG) Release: REVLIMID® and VIDAZA® Combination Therapy Achieves Nearly 30 Percent Complete Response in Untreated Elderly Patients With Acute Myeloid Leukemia
12/11/2012
More...
|
Celgene International Sárl (CELG) Release: Analysis of Post-Progression Outcomes in MM-015 Study Presented at the 54th American Society of Hematology Annual Meeting
12/11/2012
More...
|